NCT06557044View on ClinicalTrials.gov

The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty:

NARecruitingINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

March 7, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

ProspectiveRandomizedDouble-blind

Interventions

DRUG

Ropivacaine

PENG block with ropivacaine

OTHER

Physiological saline

Placebo control

Trial Locations (1)

70176

RECRUITING

Diakonie-Klinikum Stuttgart, Stuttgart

All Listed Sponsors

collaborator

University Hospital Tuebingen

OTHER

lead

Diakonie-Klinikum Stuttgart

OTHER

NCT06557044 - The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty: | Biotech Hunter | Biotech Hunter